Wednesday, 21 March 2018    HomeAbout UsContact Us    

You are here: Home Articles

Variation in Antibody Response to Oral Polio Vaccines Amongst Children
Posted by vaccinesme, in Articles
Topics: OPV Oral Polio Vaccine Seroconversion

  Mail To Friend    Printer Friendly Bookmark and Share

Roland W Sutter, Peter A Patriarca, Ali Jaffer M Suleiman, Mark A Pallansch, Elizabeth R Zell, Pradeep G Malankar, Shaun Brogan, Ahmed A K Al-Ghassani And Musallam S El-Bualy. Paralytic Poliomyelitis In Oman: Association Between Regional Differences In Attack Rate And Variations In antibody Responses To Oral Poliovirus Vaccine. International Journal Of Epidemiology, 1993, Volume 22, Number 5, Pp. 936-944.

Division of immunization (EO5) Atlanta, GA 30333, USA Ministry of health Muscat, Oman

Division of Viral and Rickettsial Diseases, Centers for disease Control Atlanta, GA 30333, USA

Reprint requests to: Information Services, National Center for Prevention Services (EO7), Centers for disease Control, Atlanta, GA 30333, USA

Variation in attack rates of paralytic disease by region during the 19881989 epidemic of type 1 poliomyelitis in Oman provided the stimulus to test the hypothesis that these observations were due to regional differences in the response of infants to trivalent oral poliovirus vaccine (OPV). Seroprevalence studies of 394 children born during the outbreak were conducted in six different regions of Oman and in two socioeconomic status (SES) groups in the capital city of Muscat; a seroconversion study was also carried out in 105 infants born after the outbreak. Seroprevalence rates by region after receipt of at least three doses of OPV ranged from 90% to 100% (median 94%) to poliovirus type 1, and from 86% to 100% (median 97%) to type 2, and from 47% to 79% [median 72%) to type 3, with the lowest rates observed in regions with the highest incidence of type 1 paralytic disease. In Muscat, seroprevalence rates were also significantly lower in low versus high SES groups (type 1: 84% versus 98%. respectively [P = 0.006]; type 3: 59% versus 86%. respectively [P = 0.001]). In the seroconversion study conducted after the outbreak, 89%. 100% and 50% of infants had detectable antibodies to types 1, 2, and 3, respectively, after four doses of OPV. Low responses to type 3 were also associated with the occurrence of sporadic cases of type 3 poliomyelitis in 1991, in spite of high rates of coverage with at least four doses of OPV (>96%) throughout the country. These findings demonstrate that antibody responses to OPV may vary widely within individual countries, and that a uniform strategy to deliver at least three doses in routine programmes may be insufficient to achieve elimination of wild poliovirus infection.

You may also want to see the following relevant article that highlights a similar issue: Vaccine Policy Lags Behind vaccine Science

Link to this article:   Show: HTML LinkFull LinkShort Link
Share or Bookmark this page: You will need to have an account with the selected service in order to post links or bookmark this page.

Subscribe via RSS or email:
Follow us through RSS or email. Click the RSS icon to subscribe to our feed.


Related Articles:
Add a Comment
You must be registered and logged in to comment.


Latest Articles
Effective or Ineffective: Attribute Framing and the Human Papillomavirus (HPV) Vaccine
CNS Demyelination and Quadrivalent HPV Vaccination
Pertussis Infection in Fully Vaccinated Children in Day-Care Centers, Israel
Chemoprevention Trial of Human Hepatitis With Selenium Supplementation in China
Protective Role of Selenium Against Hepatitis B Virus and Primary Liver Cancer in Qidong
An Increase in Selenium Intake Improves Immune Function and Poliovirus Handling in Adults With Marginal Selenium Status
Nutritional and Food Protection Against Epidemic Emerging Neuropathy. Epidemiological Findings in the Unique Disease-Free Urban Area of Cuba
Diphtheria-Tetanus-Pertussis Vaccine Administered Simultaneously With Measles Vaccine Is Associated With Increased Morbidity and Poor Growth in Girls
Children Vaccinated With MMR and Higher Risk of Multiple Sclerosis
A Possible Central Mechanism in Autism Spectrum Disorders

No pages found.

Most Popular
What Is Vaccine Failure?
Measles Outbreak in Previously Immunized Children, Florida, US
Antibody Response To Vaccine Does Not Equal Immunity or Protection
Protective Effect of Childhood Measles Against Degenerative Diseases in Later Life
Discontinuation of BCG Vaccine in Japan Leads To Significant Drop in Type 2 Diabetes
Explaining the Reemergence of Pertussis in Vaccinated Populations
Explosive School-Based Measles Outbreak in Vaccinated Students - Finland
The Myth Of Vaccines Causing 20th Century Mortality Decline: Excellent Paper by Mckinlay and Mckinlay
Graphical Evidence: Vaccination Did Not Save Populations - Data From Australia
BCG (Tuberculosis) Vaccine Induced Inflammation Linked to Type 2 Diabetes Epidemic

Archives (View more)
2011 • December
2011 • October
2010 • February
2009 • June
2009 • May
2009 • April
2009 • March
2009 • February
2009 • January

Popular Topics
mortality declinemeaslesmortality ratesmeasles outbreaksVitamin AVitamin Cmeasles deathsmeasles outbreakvaccine failuresecondary vaccine failuremumpsMMRmumps outbreakrubini strainantibodiesantibodymumps vaccineaseptic meningitisenterovirusechovirusurabe strainrubellapregnancyautismparkinsons diseasemeasles vaccineadverse reactionsGuillain-Barre Syndromebrain injurydeathGeorge Fishervaccine deathvaccine compensationpoliovaccine damagereverse transcriptaseretroviruseschicken poxvaricellapertussiswhooping coughDTPdiptheriatetanusdiabetesBCGHIBHemophilus BasthmaallergiesmercurythimerosalgardasilHPVASDBailey BanksHerd Immunitypneumoniaprevnarpneumococcalotitispediacelpsoriasisflu vaccineHepatitis BHepatitis APseudolymphomaaluminium hydroxideallergyatopyCRSmeningitisinfectionsvaccination policyvaccination scienceOPVoral polio vaccineseroconversionvaccine marketingcervical cancerinfluenzaDPTchickenpoxvaccinationimmunizationnatural immunityvaccine efficacyreinfectionmultiple sclerosisprimary vaccine failureGuillain-BarreSIDSsudden deatharthritisadjuvantsaluminiumchronic fatigueexcitotoxinsimmunoexcitotoxinsSelenium
Copyright © 2018 . All rights reserved. RSSTagsPrivacyLegal and Terms of UseSitemap